GlassScriptPhysician profile
Ryan O'Shaughnessy
NPI 1336883479
$610.50
in general payments reported to CMS, 2019-2025
9 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $191 · 2024: $198 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $203.51 | 2023-2025 | Dysport |
| Si-Bone, INC. | $166.78 | 2024-2025 | |
| Amgen INC. | $61.61 | 2023 | Evenity |
| Trice Medical, INC. | $53.01 | 2023-2025 | |
| Ucb, INC. | $48.60 | 2023 | Briviact |
| Fidia Pharma USA INC. | $23.53 | 2024 | Hymovis |
| Organon LLC | $19.87 | 2023 | Renflexis |
| Collegium Pharmaceutical, INC. | $17.19 | 2024 | Xtampza |
| Abbvie INC. | $16.40 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan O'Shaughnessy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.